Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Lung Neoplasms 2Glioma 2Carcinoma, Non-Small-Cell Lung 2Urinary Bladder Neoplasms 1Urethral Neoplasms 1Ureteral Neoplasms 1Sarcoma 1Rhabdomyosarcoma 1Pheochromocytoma 1Paraganglioma 1Papillary renal cell carcinoma, sporadic 1Pancreatic Ductal Adenocarcinoma 1Osteoradionecrosis 1Mouth Neoplasms 1Melanoma 1Hereditary leiomyomatosis and renal cell cancer 1Gliosarcoma 1Fallopian Tube Mucinous Adenocarcinoma 1Craniopharyngioma 1Colorectal Neoplasms 1Carcinoma, Renal Cell 1Brain Neoplasms 1

Interventions

Radiotherapy 2Proton Therapy 2trifluridine tipiracil drug combination 1tovorafenib 1tocilizumab 1binimetinib 1Tumor Burden 1Transurethral Resection of Bladder 1Surgical Procedures, Operative 1Oxaliplatin 1Nivolumab 1Methionine 1Leucovorin 1Fluorouracil 1Exenatide 1Contrast Media 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Craniopharyngioma × Contrast Media × 90 days × Clear all
NCT01419067 2026-04-29

A Phase II Trial of Limited Surgery and Proton Therapy for Craniopharyngioma or Observation After Radical Resection

St. Jude Children's Research Hospital

Phase 2 Active not recruiting
112 enrolled
CNS

Craniopharyngioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡